MabCure, Inc. (MBCI)

Market Cap	78.11K
Revenue (ttm)	500.00K
Net Income (ttm)	-12.26M
Shares Out	781.09M
EPS (ttm)	-0.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	525
Average Volume	51,106
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0003
Beta	10.18
RSI	47.80
Earnings Date	n/a

About MabCure

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains...

• Industry: Solar
• Sector: Technology
• Founded: 2006
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: MBCI